Structure-Activity Relationship Studies of 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine (FPMINT) Analogues as Inhibitors of Human Equilibrative Nucleoside Transporters

被引:3
作者
Li, Renkai [1 ]
Mak, Winston Wing-Shum [1 ]
Li, Jingjing [1 ]
Zheng, Chengwen [1 ]
Shiu, Polly Ho-Ting [1 ]
Seto, Sai-Wang [2 ]
Lee, Simon Ming-Yuen [3 ]
Leung, George Pak-Heng [1 ]
机构
[1] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Peoples R China
[2] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China
[3] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Ave Univ, Taipa, Macao, Peoples R China
关键词
equilibrative nucleoside transporter; inhibitor; structure-activity relationship; FPMINT; mechanism of action; ADENOSINE UPTAKE; NITROBENZYLMERCAPTOPURINE RIBOSIDE; FUNCTIONAL-CHARACTERIZATION; EI; CLONING; POTENT; DRUGS; CELLS; ENT1; ES;
D O I
10.3389/fphar.2022.837555
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Equilibrative nucleoside transporters (ENTs) play a vital role in nucleotide synthesis, regulation of adenosine function and chemotherapy. Current inhibitors of ENTs are mostly ENT1-selective. Our previous study has demonstrated that 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine (FPMINT) is a novel inhibitor of ENTs, which is more selective to ENT2 than to ENT1. The present study aimed to screen a series of FPMINT analogues and study their structure-activity relationship. Nucleoside transporter-deficient cells transfected with cloned human ENT1 and ENT2 were used as in vitro models. The results of the [H-3]uridine uptake study showed that the replacement of the naphthalene moiety with the benzene moiety could abolish the inhibitory effects on ENT1 and ENT2. The addition of chloride to the meta position of this benzene moiety could restore only the inhibitory effect on ENT1 but had no effect on ENT2. However, the addition of the methyl group to the meta position or the ethyl or oxymethyl group to the para position of this benzene moiety could regain the inhibitory activity on both ENT1 and ENT2. The presence of a halogen substitute, regardless of the position, in the fluorophenyl moiety next to the piperazine ring was essential for the inhibitory effects on ENT1 and ENT2. Among the analogues tested, compound 3c was the most potent inhibitor. Compound 3c reduced V-max of [H-3]uridine uptake in ENT1 and ENT2 without affecting K-m. The inhibitory effect of compound 3c could not be washed out. Compound 3c did not affect cell viability, protein expression and internalization of ENT1 and ENT2. Therefore, similar to FPMINT, compound 3c was an irreversible and non-competitive inhibitor. Molecular docking analysis also showed that the binding site of compound 3c in ENT1 may be different from that of other conventional inhibitors. It is expected that structural modification may further improve its potency and selectivity and lead to the development of useful pharmacological agents.
引用
收藏
页数:11
相关论文
共 40 条
  • [1] Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes
    Baldwin, SA
    Yao, SYM
    Hyde, RJ
    Ng, AML
    Foppolo, S
    Barnes, K
    Ritzel, MWL
    Cass, CE
    Young, JD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (16) : 15880 - 15887
  • [2] The equilibrative nucleoside transporter family, SLC29
    Baldwin, SA
    Beal, PR
    Yao, SYM
    King, AE
    Cass, CE
    Young, JD
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2004, 447 (05): : 735 - 743
  • [3] Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH
    Barnes, Kay
    Dobrzynski, Halina
    Foppolo, Sophie
    Beal, Paul R.
    Ismat, Fouzia
    Scullion, Elspeth R.
    Sun, Lijie
    Tellez, James
    Ritzel, Mabel W. L.
    Claycomb, William C.
    Cass, Carol E.
    Young, James D.
    Billeter-Clark, Rudi
    Boyett, Mark R.
    Baldwin, Stephen A.
    [J]. CIRCULATION RESEARCH, 2006, 99 (05) : 510 - 519
  • [4] Aryl- and heteroaryl-substituted aminobenzo[a]quinolizines as dipeptidyl peptidase IV inhibitors
    Boehringer, Markus
    Fischer, Holger
    Hennig, Michael
    Hunziker, Daniel
    Huwyler, Joerg
    Kuhn, Bernd
    Loeffler, Bernd M.
    Luebbers, Thomas
    Mattei, Patrizio
    Narquizian, Robert
    Sebokova, Elena
    Sprecher, Urs
    Wessel, Hans Peter
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 1106 - 1108
  • [5] Transporters that translocate nucleosides and structural similar drugs: structural requirements for substrate recognition
    Cano-Soldado, Pedro
    Pastor-Anglada, Marcal
    [J]. MEDICINAL RESEARCH REVIEWS, 2012, 32 (02) : 428 - 457
  • [6] Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line
    Crawford, CR
    Patel, DH
    Naeve, C
    Belt, JA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (09) : 5288 - 5293
  • [7] Hepatotoxicity of piperazine designer drugs: Comparison of different in vitro models
    Dias-da-Silva, D.
    Arbo, M. D.
    Valente, M. J.
    Bastos, M. L.
    Carmo, H.
    [J]. TOXICOLOGY IN VITRO, 2015, 29 (05) : 987 - 996
  • [8] Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury
    Eckle, Tobias
    Hughes, Kelly
    Ehrentraut, Heidi
    Brodsky, Kelley S.
    Rosenberger, Peter
    Choi, Doo-Sup
    Ravid, Katya
    Weng, Tingting
    Xia, Yang
    Blackburn, Michael R.
    Eltzschig, Holger K.
    [J]. FASEB JOURNAL, 2013, 27 (08) : 3078 - 3089
  • [9] Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3
    Govindarajan, Rajgopal
    Leung, George P. H.
    Zhou, Mingyan
    Tse, Chung-Ming
    Wang, Joanne
    Unadkat, Jashvant D.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2009, 296 (04): : G910 - G922
  • [10] Molecular Cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta
    Griffiths, M
    Yao, SYM
    Abidi, F
    Phillips, SEV
    Cass, CE
    Young, JD
    Baldwin, SA
    [J]. BIOCHEMICAL JOURNAL, 1997, 328 : 739 - 743